Hepatitis C Antibodies

"Hepatitis C Antibodies" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Antibodies to the HEPATITIS C ANTIGENS including antibodies to envelope, core, and non-structural proteins.

Descriptor ID	D018937
MeSH Number(s)	D12.776.124.486.485.114.254.450.510 D12.776.124.790.651.114.254.450.510 D12.776.377.715.548.114.254.450.510
Concept/Terms	Hepatitis C Antibodies Hepatitis C Antibodies Hepatitis C Virus Antibodies HCV Antibodies Anti-HCV Antibodies Anti HCV Antibodies Anti-Hepatitis C Virus Antibodies Anti Hepatitis C Virus Antibodies

Below are MeSH descriptors whose meaning is more general than "Hepatitis C Antibodies".

Chemicals and Drugs [D]
Amino Acids, Peptides, and Proteins [D12]
Proteins [D12.776]
Blood Proteins [D12.776.124]
Immunoproteins [D12.776.124.486]
Immunoglobulins [D12.776.124.486.485]
Antibodies [D12.776.124.486.485.114]
Antibodies, Viral [D12.776.124.486.485.114.254]
Hepatitis Antibodies [D12.776.124.486.485.114.254.450]
Hepatitis C Antibodies [D12.776.124.486.485.114.254.450.510]
Serum Globulins [D12.776.124.790]
Immunoglobulins [D12.776.124.790.651]
Antibodies [D12.776.124.790.651.114]
Antibodies, Viral [D12.776.124.790.651.114.254]
Hepatitis Antibodies [D12.776.124.790.651.114.254.450]
Hepatitis C Antibodies [D12.776.124.790.651.114.254.450.510]
Globulins [D12.776.377]
Serum Globulins [D12.776.377.715]
Immunoglobulins [D12.776.377.715.548]
Antibodies [D12.776.377.715.548.114]
Antibodies, Viral [D12.776.377.715.548.114.254]
Hepatitis Antibodies [D12.776.377.715.548.114.254.450]
Hepatitis C Antibodies [D12.776.377.715.548.114.254.450.510]

Below are MeSH descriptors whose meaning is related to "Hepatitis C Antibodies".

Below are MeSH descriptors whose meaning is more specific than "Hepatitis C Antibodies".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Hepatitis C Antibodies" by people in this website by year, and whether "Hepatitis C Antibodies" was a major or minor topic of these publications.

Bar chart showing 9 publications over 8 distinct years, with a maximum of 2 publications in 2007

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2002	1	0	1
2003	0	1	1
2004	1	0	1
2007	1	1	2
2009	1	0	1
2011	0	1	1
2015	0	1	1
2022	0	1	1

Below are the most recent publications written about "Hepatitis C Antibodies" by people in Profiles.

Ozga JE, Syvertsen JL, Pollini RA. Hepatitis C antibody prevalence, correlates and barriers to care among people who inject drugs in Central California. J Viral Hepat. 2022 07; 29(7):518-528.

View in: PubMed
Zhang S, Bakshi RK, Suneetha PV, Fytili P, Antunes DA, Vieira GF, Jacobs R, Klade CS, Manns MP, Kraft AR, Wedemeyer H, Schlaphoff V, Cornberg M. Frequency, Private Specificity, and Cross-Reactivity of Preexisting Hepatitis C Virus (HCV)-Specific CD8+ T Cells in HCV-Seronegative Individuals: Implications for Vaccine Responses. J Virol. 2015 Aug; 89(16):8304-17.

View in: PubMed
Jolly PE, Shuaib FM, Jiang Y, Preko P, Baidoo J, Stiles JK, Wang JS, Phillips TD, Williams JH. Association of high viral load and abnormal liver function with high aflatoxin B1-albumin adduct levels in HIV-positive Ghanaians: preliminary observations. Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 2011 Sep; 28(9):1224-34.

View in: PubMed
Soto-Salgado M, P?rez CM, Burgos-Calder?n R, Torres EA, Su?rez E. Factors associated to the prevalence of antibodies to hepatitis C virus among patients receiving hemodialysis at selected dialysis centers in Puerto Rico, 2005. P R Health Sci J. 2009 Mar; 28(1):18-23.

View in: PubMed
P?rez CM, Albizu C, Pe?a M, Torres EA, Reyes JC, Col?n H, Ortiz AP, Su?rez E. Hepatitis C in Puerto Rico: a time for public health action. P R Health Sci J. 2007 Dec; 26(4):395-400.

View in: PubMed
Trepka MJ, Zhang G, Leguen F, Obiaja K, Malow RM, De La Rosa M. Benefits and adverse effects of hepatitis C screening: early results of a screening program. J Public Health Manag Pract. 2007 May-Jun; 13(3):263-9.

View in: PubMed
Carlos MP, Yamamura Y, Vu Q, Conzen K, Anderson DE, Torres JV. Humoral immunity to immunodominant epitopes of Hepatitis C virus in individuals infected with genotypes 1a or 1b. Clin Immunol. 2004 Apr; 111(1):22-7.

View in: PubMed
Krause G, Trepka MJ, Whisenhunt RS, Katz D, Nainan O, Wiersma ST, Hopkins RS. Nosocomial transmission of hepatitis C virus associated with the use of multidose saline vials. Infect Control Hosp Epidemiol. 2003 Feb; 24(2):122-7.

View in: PubMed
Chung RT, Evans SR, Yang Y, Theodore D, Valdez H, Clark R, Shikuma C, Nevin T, Sherman KE. Immune recovery is associated with persistent rise in hepatitis C virus RNA, infrequent liver test flares, and is not impaired by hepatitis C virus in co-infected subjects. AIDS. 2002 Sep 27; 16(14):1915-23.

View in: PubMed
Gangaidzo IT, Moyo VM, Khumalo H, Saungweme T, Gomo Z, Rouault T, Gordeuk VR. Hepatitis C virus in Zimbabwe. Cent Afr J Med. 1997 May; 43(5):122-5.

View in: PubMed

People

Explore

Similar Concepts

Top Journals